RECURRENT ADULT ACUTE MYELOID LEUKEMIA
Clinical trials for RECURRENT ADULT ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT ADULT ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for RECURRENT ADULT ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo aims to control aggressive blood cancers
Disease control OngoingThis study is testing the safety and effectiveness of combining two drugs, vorinostat and azacitidine, for patients with myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML). The goal is to find the best dose and see if the combination can better control the disease by…
Matched conditions: RECURRENT ADULT ACUTE MYELOID LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New radiation technique tested in fight against relapsed blood cancers
Disease control TerminatedThis study is testing a new, more targeted form of radiation to the bone marrow (called IMTMI) given with two chemotherapy drugs before a second stem cell transplant. The goal is to see if this combination is safe and can better prepare patients with advanced blood cancers (like …
Matched conditions: RECURRENT ADULT ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for older leukemia patients ineligible for harsh chemo
Disease control OngoingThis study is testing the safety and best dose of an experimental drug, nintedanib, when combined with an approved drug, azacitidine. It is for older adults with a specific type of acute myeloid leukemia who are not candidates for or choose to avoid intensive chemotherapy. The ma…
Matched conditions: RECURRENT ADULT ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: Northwestern University • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
Scientists Re-Engineer Patient's own cells to hunt down leukemia
Disease control OngoingThis early-stage study is testing a new type of cellular therapy for adults with acute myeloid leukemia or a related blood cancer that has come back or not responded to standard treatments. Doctors collect a patient's or donor's immune cells, genetically modify them in a lab to b…
Matched conditions: RECURRENT ADULT ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 16, 2026 15:27 UTC
-
New strategy aims to tame dangerous virus after cancer transplant
Disease control OngoingThis study is testing a personalized plan to manage cytomegalovirus (CMV), a common and potentially serious infection, in patients who have received a donor stem cell transplant for blood cancers or disorders. The plan involves closely monitoring the virus level and the patient's…
Matched conditions: RECURRENT ADULT ACUTE MYELOID LEUKEMIA
Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
Scientists test new drug cocktail in fight against tough blood cancer
Disease control OngoingThis early-stage study is testing a combination of three drugs—bortezomib, sorafenib, and decitabine—to treat acute myeloid leukemia (AML). The main goal is to find the safest and most effective dose. The study is for adults with AML who are older, have a type that is hard to tre…
Matched conditions: RECURRENT ADULT ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 02, 2026 15:24 UTC